Literature DB >> 178475

Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns.

I Feinberg, R Jones, J Walker, C Cavness, T Floyd.   

Abstract

Marijuana extract, given in daily doses containing 70 to 210 mg delta-9-tetrahydrocannabinol (THC), induced effects on sleep that were virtually identical to those produced by the same doses of relatively pure (96%) THC. Both drugs reduced eye movements density with some tolerance developing to this effect. Stage 4 tendend to increase with drug administration. Abrupt withdrawal led to extremely high densities of eye movement, increased rapid eye movement (REM) durations, and a sharp but transient fall in stage 4 to baseline levels. These effects may be useful in the elucidation of the pharmacology of sleep. The effects on sleep of THC administration (but not withdrawal) closely resemble those induced by lithium. For this reason, we suggest further studies of THC in affective disorders. Evidence available thus far suggests that THC produces dysphoric symptoms in unipolar but not in bipolar depressed patients; these differences in response may prove of diagnostic value. An adequate therapeutic trial of THC in bipolar depressed patients has not yet been carried out.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178475     DOI: 10.1002/cpt1976196782

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  28 in total

1.  Differential Effects of Addictive Drugs on Sleep and Sleep Stages.

Authors:  Harold W Gordon
Journal:  J Addict Res (OPAST Group)       Date:  2019-07-15

Review 2.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Authors:  Kimberly A Babson; James Sottile; Danielle Morabito
Journal:  Curr Psychiatry Rep       Date:  2017-04       Impact factor: 5.285

3.  Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.

Authors:  Karen I Bolla; Suzanne R Lesage; Charlene E Gamaldo; David N Neubauer; Nae-Yuh Wang; Frank R Funderburk; Richard P Allen; Paula M David; Jean Lud Cadet
Journal:  Sleep Med       Date:  2010-08-03       Impact factor: 3.492

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  The spread of sleep loss influences drug use in adolescent social networks.

Authors:  Sara C Mednick; Nicholas A Christakis; James H Fowler
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

6.  Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome.

Authors:  Sarah S Farabi; Bharati Prasad; Lauretta Quinn; David W Carley
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

7.  EEG of chronic marijuana users during abstinence: relationship to years of marijuana use, cerebral blood flow and thyroid function.

Authors:  Ronald I Herning; Warren Better; Jean L Cadet
Journal:  Clin Neurophysiol       Date:  2007-12-11       Impact factor: 3.708

8.  Sleep disturbance in heavy marijuana users.

Authors:  Karen I Bolla; Suzanne R Lesage; Charlene E Gamaldo; David N Neubauer; Frank R Funderburk; Jean Lud Cadet; Paula M David; Antonio Verdejo-Garcia; Amy R Benbrook
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

Review 9.  Functional consequences of marijuana use in adolescents.

Authors:  J Jacobus; S Bava; M Cohen-Zion; O Mahmood; S F Tapert
Journal:  Pharmacol Biochem Behav       Date:  2009-04-05       Impact factor: 3.533

10.  Endocannabinoid Signaling Regulates Sleep Stability.

Authors:  Matthew J Pava; Alexandros Makriyannis; David M Lovinger
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.